Clinical performance of human papillomavirus based cervical cancer screening algorithm: The result of a large Danish implementation study

被引:0
|
作者
Lindquist, Sofie [1 ]
Kjaer, Susanne K. [1 ,2 ,3 ]
Frederiksen, Kirsten [4 ]
Ornskov, Dorthe [5 ]
Petersen, Lone Kjeld [6 ,7 ]
Munk, Christian [1 ]
Waldstrom, Marianne [8 ,9 ]
机构
[1] Danish Canc Inst, Unit Virus Lifestyle & Genes, Copenhagen, Denmark
[2] Copenhagen Univ Hosp, Dept Gynecol, Rigshosp, Copenhagen, Denmark
[3] Univ Copenhagen, Dept Clin Med, Copenhagen, Denmark
[4] Danish Canc Inst, Unit Stat Biostat & Registry, Copenhagen, Denmark
[5] Odense Univ Hosp, Dept Pathol, Odense, Denmark
[6] Odense Univ Hosp, Dept Obstet & Gynecol, Odense, Denmark
[7] Univ Southern Denmark, Dept Clin Med, Odense, Denmark
[8] Aarhus Univ Hosp, Dept Pathol, Aarhus, Denmark
[9] Aarhus Univ, Dept Clin Med, Aarhus, Denmark
关键词
cervical cancer; cervical intraepithelial neoplasia; HPV testing; human papillomavirus; screening; BIOPSIES;
D O I
10.1111/aogs.14915
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
IntroductionIn Denmark, where human papillomavirus (HPV) -based cervical cancer screening is being implemented, the aim of this pilot implementation study was to test a specific screening algorithm, assess follow-up examination attendance, and measure the proportion of precancer lesions found in relation to the number of women referred for colposcopy.Material and MethodsFrom May 2017 to December 2020, 36 417 women in the uptake area of the Department of Pathology, Vejle Hospital, Region of Southern Denmark, were included in the HPV group. Women positive for HPV16/18 irrespective of cytology and women positive for other high-risk HPV (hrHPV) types having concomitant abnormal cytology were referred directly to colposcopy. Women positive for other hrHPV types and normal cytology were referred to repeat screening after 12 months, and hrHPV negative to routine screening after three years. We obtained information on screening results and subsequent histological diagnosis from the Danish Pathology Databank through September 2022.Results3.6% of the women were referred to colposcopy after primary screening, 5% to repeat screening after 12 months, and 91.4% back to routine screening. High follow-up rates were observed: 96% attended colposcopy after primary screening, with 91% attending colposcopy after repeat screening. CIN3+ was detected at colposcopy following the primary screening in 28.1% of HPV16/18-positive women and 18.2% of those positive for other hrHPV types with concomitant abnormal cytology. Of the women with other hrHPV and simultaneous ASCUS/LSIL, 8% had CIN3+. At the repeat screening, 43% had become hrHPV negative, 55% were persistently positive for other hrHPV, and 2% had turned positive for HPV16/18. At the colposcopy following repeat screening, 10.1% of the women positive for other hrHPV were diagnosed with CIN3+, in comparison with 11.1% of the HPV16/18-positive women.ConclusionsIn this pilot implementation study, an algorithm for HPV-based screening was evaluated in a Danish setting. The results demonstrated high attendance at follow-up examinations and provided insights into the number of colposcopy referrals and the detection of CIN2 and CIN3+ cases. The results suggest that women testing positive for other hrHPV in combination with ASCUS/LSIL at primary screening could potentially be referred to repeat screening instead of an immediate colposcopy. This Danish pilot study assessed an HPV-based screening algorithm, revealing a high follow-up attendance. Positive hrHPV with ASCUS/LSIL may motivate repeat screening after 12 months, potentially reducing immediate colposcopy referrals while maintaining effective detection of CIN2 and CIN3+ cases.image
引用
收藏
页码:1781 / 1788
页数:8
相关论文
共 50 条
  • [31] An evaluation of liquid-based cytology and human papillomavirus testing within the UK cervical cancer screening programme
    C Sherlaw-Johnson
    Z Philips
    British Journal of Cancer, 2004, 91 : 84 - 91
  • [32] Comparison of human papillomavirus-based cervical cancer screening strategies in Tanzania among women with and without HIV
    Kahesa, Crispin
    Thomsen, Louise T.
    Linde, Ditte S.
    Mchome, Bariki
    Katanga, Johnson
    Swai, Patricia
    Manongi, Rachel
    Kjaerem, Myassa
    Iftner, Thomas
    Waldstrom, Marianne
    Mwaiselage, Julius
    Rasch, Vibeke
    Kjaer, Susanne K.
    INTERNATIONAL JOURNAL OF CANCER, 2023, 152 (04) : 686 - 696
  • [33] An evaluation of liquid-based cytology and human papillomavirus testing within the UK cervical cancer screening programme
    Sherlaw-Johnson, C
    Philips, Z
    BRITISH JOURNAL OF CANCER, 2004, 91 (01) : 84 - 91
  • [34] Approaches for triaging women who test positive for human papillomavirus in cervical cancer screening
    Tota, Joseph E.
    Bentley, James
    Blake, Jennifer
    Coutlee, Francois
    Duggan, Maire A.
    Ferenczy, Alex
    Franco, Eduardo L.
    Fung-Kee-Fung, Michael
    Gotlieb, Walter
    Mayrand, Marie-Helene
    McLachlin, Meg
    Murphy, Joan
    Ogilvie, Gina
    Ratnam, Sam
    PREVENTIVE MEDICINE, 2017, 98 : 15 - 20
  • [35] Evaluation of human-papillomavirus testing and visual inspection for cervical cancer screening in Rwanda
    Umulisa, M. Chantal
    Franceschi, Silvia
    Baussano, Iacopo
    Tenet, Vanessa
    Uwimbabazi, Mathilde
    Rugwizangoga, Belson
    Heideman, Danielle A. M.
    Uyterlinde, Anne M.
    Darragh, Teresa M.
    Snijders, Peter J. F.
    Sayinzoga, Felix
    Clifford, Gary M.
    BMC WOMENS HEALTH, 2018, 18
  • [36] Evaluation of human-papillomavirus testing and visual inspection for cervical cancer screening in Rwanda
    M. Chantal Umulisa
    Silvia Franceschi
    Iacopo Baussano
    Vanessa Tenet
    Mathilde Uwimbabazi
    Belson Rugwizangoga
    Daniëlle A. M. Heideman
    Anne M. Uyterlinde
    Teresa M. Darragh
    Peter J. F. Snijders
    Felix Sayinzoga
    Gary M. Clifford
    BMC Women's Health, 18
  • [37] Clinical Utility of Human Papillomavirus Genotyping in Cervical Cancer Screening: A Systematic Review
    Bonde, Jesper H.
    Sandri, Maria-Teresa
    Gary, Devin S.
    Andrews, Jeffrey C.
    JOURNAL OF LOWER GENITAL TRACT DISEASE, 2020, 24 (01) : 1 - 13
  • [38] Human papillomavirus vaccination and subsequent cervical cancer screening in a large integrated healthcare system
    Chao, Chun
    Silverberg, Michael J.
    Becerra, Tracy A.
    Corley, Douglas A.
    Jensen, Christopher D.
    Chen, Qiaoling
    Quinn, Virginia P.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2017, 216 (02) : 151.e1 - 151.e9
  • [39] Detection of human papillomavirus DNA by PCR/microfluorometry for screening of cervical cancer
    Yamaguchi, A
    Hashimoto, N
    Tsutae, W
    Seino, K
    Ebina, Y
    Tokino, T
    Sato, N
    Kikuchi, K
    CLINICA CHIMICA ACTA, 2002, 318 (1-2) : 41 - 49
  • [40] Human papillomavirus vaccines versus cervical cancer screening
    Stantey, M.
    CLINICAL ONCOLOGY, 2008, 20 (06) : 388 - 394